SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 76 filers reported holding SAVARA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $330,560 | +3.7% | 82,025 | +28.1% | 0.00% | – |
| Q1 2024 | $318,791 | +803.3% | 64,014 | +752.5% | 0.00% | – |
| Q4 2023 | $35,292 | +24.3% | 7,509 | 0.0% | 0.00% | – |
| Q3 2023 | $28,384 | +20.8% | 7,509 | +2.1% | 0.00% | – |
| Q2 2023 | $23,506 | +235.8% | 7,357 | +104.9% | 0.00% | – |
| Q1 2021 | $7,000 | +75.0% | 3,590 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 3,590 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -73.3% | 3,590 | -38.8% | 0.00% | – |
| Q2 2020 | $15,000 | +25.0% | 5,863 | +1.0% | 0.00% | – |
| Q1 2020 | $12,000 | -53.8% | 5,803 | 0.0% | 0.00% | – |
| Q4 2019 | $26,000 | +116.7% | 5,803 | +30.7% | 0.00% | – |
| Q3 2019 | $12,000 | +9.1% | 4,440 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | -66.7% | 4,440 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | -2.9% | 4,440 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | -32.0% | 4,440 | 0.0% | 0.00% | – |
| Q3 2018 | $50,000 | +19.0% | 4,440 | +19.2% | 0.00% | – |
| Q2 2018 | $42,000 | – | 3,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 4,980,804 | $16,026,005 | 46.25% |
| NEA Management Company, LLC | 24,137,931 | $77,120,690 | 5.89% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $37,134,201 | 3.82% |
| VR Adviser, LLC | 6,351,531 | $20,293,142 | 3.24% |
| Sio Capital Management, LLC | 1,010,701 | $3,229,190 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 198,139 | $633,054 | 0.43% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,908,086 | $34,851,335 | 0.18% |
| Parkman Healthcare Partners LLC | 206,607 | $660,109 | 0.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,064,551 | $19,376,240 | 0.04% |
| ClariVest Asset Management LLC | 242,900 | $776 | 0.04% |